NSPR
BEARISH
$1.35
Live
InspireMD, Inc. · NASDAQ
Target $5.0
(+270.4%)
$1.28
52W Range
$2.93
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Confidence
85%
NSPR exhibits severe financial distress as evidenced by a Piotroski F-Score of 1/9, indicating critical weakness in fundamental health. While the company shows impressive top-line revenue growth of 61.6% and maintains a strong liquidity position with a current ratio of 5.74, these are overshadowed by an unsustainable operating margin of -383.74% and a deeply negative ROE of -106.89%. The technical trend is entirely bearish, and the stock is trading near its 52-week low despite optimistic analyst price targets.
Key Strengths
Strong YoY revenue growth of 61.60%
High liquidity with a current ratio of 5.74
Very low leverage with a Debt/Equity ratio of 0.06
Consistent history of beating EPS estimates
Significant gap between current price ($1.35) and analyst target ($5.00)
Key Risks
Critical financial health (Piotroski F-Score 1/9)
Extreme operational inefficiency (Operating Margin -383.74%)
Severe negative shareholder returns (ROE -106.89%)
Strong bearish technical momentum (1Y change -45.1%)
Micro-cap volatility and lack of profitability
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare NSPR against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning NSPR from our newsroom.
Newest → oldest
No matching news yet.